Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 6

1.

Noninvasive Ventilation Versus High-Flow Nasal Oxygen for Acute Respiratory Distress Syndrome: Where Next?

Sovani MP, Esquinas AM.

Crit Care Med. 2018 Oct;46(10):e1018-e1019. doi: 10.1097/CCM.0000000000003284. No abstract available.

PMID:
30216327
2.

What is the potential role of transcutaneous carbon dioxide in guiding acute noninvasive ventilation?

van Oppen JD, Daniel PS, Sovani MP.

Respir Care. 2015 Apr;60(4):484-91. doi: 10.4187/respcare.03335. Epub 2014 Nov 18.

3.

Systemic and bronchodilator effects of inhaled rac-formoterol in subjects with chronic obstructive pulmonary disease: a dose-response study.

Whale CI, Sovani MP, Mortimer KJ, Harrison TW, Tattersfield AE.

Br J Clin Pharmacol. 2008 Jun;65(6):841-7. doi: 10.1111/j.1365-2125.2007.03081.x. Epub 2008 Apr 3.

4.

Poor adherence with inhaled corticosteroids for asthma: can using a single inhaler containing budesonide and formoterol help?

Sovani MP, Whale CI, Oborne J, Cooper S, Mortimer K, Ekström T, Tattersfield AE, Harrison TW.

Br J Gen Pract. 2008 Jan;58(546):37-43. doi: 10.3399/bjgp08X263802.

5.

Effects of rac-albuterol on arterial blood gases in patients with stable hypercapnic chronic obstructive pulmonary disease.

Whale CI, Sovani MP, Mortimer K, Oborne J, Cooper S, Harrison TW, Tattersfield AE.

Br J Clin Pharmacol. 2006 Aug;62(2):153-7.

6.

A benefit-risk assessment of inhaled long-acting beta2-agonists in the management of obstructive pulmonary disease.

Sovani MP, Whale CI, Tattersfield AE.

Drug Saf. 2004;27(10):689-715. Review.

PMID:
15350154

Supplemental Content

Loading ...
Support Center